[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Endocrinology](https://durgical.com/en/endocrinology/) › [Endocrine tumours and inherited syndromes](https://durgical.com/en/endocrinology/areas/tumours-genetics/) › Endocrine side effects of immune checkpoint inhibitors

# Endocrine side effects of immune checkpoint inhibitors

- Diagnostic approach

Cancer immunotherapy can turn the immune system on the thyroid, pituitary, [pancreas](https://durgical.com/en/anatomy/pancreas/) or adrenals. The damage lasts, but replacing hormones lets treatment go on.

Updated Nov 16, 2026

**See it in 3D:** [Pituitary gland](https://durgical.com/en/anatomy/pituitary-gland/) · [Thyroid gland](https://durgical.com/en/anatomy/thyroid-gland/) · [Pancreas](https://durgical.com/en/anatomy/pancreas/) · [Left adrenal gland](https://durgical.com/en/anatomy/left-suprarenal-gland/)

## Key points

- PD-1/PD-L1 → [thyroiditis](https://durgical.com/en/conditions/thyroiditis/) (thyrotoxic then hypothyroid) and diabetes; CTLA-4 → hypophysitis.
- Hypophysitis: ACTH deficiency, usually permanent; [diabetes insipidus](https://durgical.com/en/conditions/diabetes-insipidus/) rare.
- Checkpoint diabetes: sudden, DKA, very low C-peptide, permanent.
- [Cortisol](https://durgical.com/en/biochemistry/molecules/cortisol/) before [thyroxine](https://durgical.com/en/biochemistry/molecules/thyroxine/).
- Replacement, not high-dose steroids; immunotherapy usually continues.

On this page

- The basics Key points
- What it is
- How to think about it
- What to know
- Step-by-step approach
- Common traps
- Elsewhere in DurgiPedia

- Clinical Keys to the differential

- Treatment Endocrine adverse events of checkpoint inhibitors: pattern, permanence and treatment
- Next step / Initial management

- Study Test yourself

- Connections Connections

## What it is

[Immune checkpoint inhibitors](https://durgical.com/en/pharmacology/classes/immune-checkpoint-inhibitors/) (anti-CTLA-4 such as [ipilimumab](https://durgical.com/en/pharmacology/ipilimumab/), anti-PD-1 such as [nivolumab](https://durgical.com/en/pharmacology/nivolumab/) and [pembrolizumab](https://durgical.com/en/pharmacology/pembrolizumab/), and anti-PD-L1) release the brakes on T cells so they attack tumours, and sometimes the patient's own glands. Endocrine immune-related adverse events are among the most frequent. Thyroiditis (mainly with PD-1/PD-L1 blockers) is the commonest; hypophysitis is typical of CTLA-4 blockers and combination therapy; insulin-deficient diabetes, primary [adrenal insufficiency](https://durgical.com/en/conditions/adrenal-insufficiency/) and [hypoparathyroidism](https://durgical.com/en/conditions/hypoparathyroidism/) are rare but dangerous. Unlike most immune side effects, endocrine damage is usually permanent and is managed with hormone replacement rather than high-dose [glucocorticoids](https://durgical.com/en/physiology/actions-of-cortisol/), so immunotherapy can usually continue.

## How to think about it

Checkpoint inhibitors cut the brakes on immunity; a gland they hit is usually burnt out for good. So do not try to put the fire out: replace what the gland made, in the right order (cortisol before thyroxine), and let the cancer treatment carry on. Read each gland with its driver hormone to tell a pituitary hit from a gland hit.

## What to know

- Thyroid disease is the most common endocrine adverse event, mostly with PD-1/PD-L1 blockers: painless destructive thyroiditis with a short thyrotoxic phase, then [hypothyroidism](https://durgical.com/en/conditions/hypothyroidism/) that is often permanent.
- The thyrotoxic phase is destructive, not overproduction: it is treated with a beta-blocker if symptomatic, never with antithyroid drugs; [Graves disease](https://durgical.com/en/conditions/graves-disease/) is rare.
- Hypophysitis is typical of CTLA-4 blockade and combination therapy, usually in the first months; it presents with headache and fatigue, and ACTH deficiency (central adrenal insufficiency) is the most important deficit.
- ACTH deficiency after checkpoint inhibitors is almost always permanent; TSH and gonadotropin deficits may recover; diabetes insipidus is rare, unlike in other forms of hypophysitis.
- Hypophysitis from PD-1 blockers often causes isolated ACTH deficiency with a normal-looking pituitary on MRI.
- Checkpoint-inhibitor diabetes is rare but sudden: insulin deficiency, often presenting as [diabetic ketoacidosis](https://durgical.com/en/conditions/diabetic-ketoacidosis/), very low C-peptide, sometimes with GAD [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/), and an [HbA1c](https://durgical.com/en/biochemistry/topics/glycated-haemoglobin/) that may be only mildly raised because the onset is so fast; it is permanent.
- Primary adrenal insufficiency (adrenalitis) is rare: high ACTH, low cortisol and mineralocorticoid deficiency with [hyponatraemia](https://durgical.com/en/conditions/hyponatraemia/) and [hyperkalaemia](https://durgical.com/en/conditions/hyperkalaemia/).
- Hypoparathyroidism is very rare and causes severe [hypocalcaemia](https://durgical.com/en/conditions/hypocalcaemia/) with low PTH.
- High-dose glucocorticoids do not restore gland function; they are used for hypophysitis only with severe mass effect such as visual loss or intractable headache.
- Immunotherapy is usually continued once replacement is in place; it is held only during an acute crisis until the patient is stable.

## Step-by-step approach

- Before the first cycle: TSH, free T4, [glucose](https://durgical.com/en/biochemistry/molecules/glucose/), electrolytes and a morning cortisol, as a baseline.
- Before each cycle: TSH with free T4 and glucose; teach the patient the warning symptoms.
- [Low TSH](https://durgical.com/en/endocrinology/subclinical-hyperthyroidism-when-a-low-tsh-matters/) with high free T4 → thyroiditis: beta-blocker for symptoms, repeat in a few weeks, expect hypothyroidism.
- Low or normal TSH with low free T4 → [central hypothyroidism](https://durgical.com/en/endocrinology/hypothyroidism-overt-subclinical-and-central/): suspect hypophysitis and check cortisol and ACTH at once.
- Low cortisol with low or normal ACTH → hypophysitis; with high ACTH → primary adrenal failure; start [hydrocortisone](https://durgical.com/en/pharmacology/hydrocortisone/).
- Replace glucocorticoid before thyroxine: thyroxine first speeds cortisol use and can trigger [adrenal crisis](https://durgical.com/en/endocrinology/adrenal-crisis/).
- High glucose, especially with ketones → treat as new insulin-deficient diabetes or DKA; measure C-peptide.
- Unwell, hypotensive, vomiting or confused → treat as adrenal crisis, DKA or severe hypocalcaemia without waiting for results.
- Once stable on replacement, continue immunotherapy; give a steroid card and [sick-day rules](https://durgical.com/en/nursing/the-child-with-type-1-diabetes-glucose-checks-insulin-teaching-hypoglycaemia-sic/).

## Endocrine adverse events of checkpoint inhibitors: pattern, permanence and treatment

| Disorder | Typical drug class | Laboratory pattern | Permanent? | Treatment |
| --- | --- | --- | --- | --- |
| Thyroiditis, thyrotoxic phase | PD-1/PD-L1 | Low TSH, high free T4, low uptake | No, transient | Beta-blocker if symptoms; no antithyroid drugs |
| Hypothyroidism | PD-1/PD-L1, after thyroiditis | High TSH, low free T4 | Usually yes | [Levothyroxine](https://durgical.com/en/pharmacology/levothyroxine/) |
| Hypophysitis | CTLA-4 or combination | Low cortisol with low ACTH; often low TSH, LH, FSH | ACTH deficit yes; others may recover | Hydrocortisone first, then other hormones as needed |
| Insulin-deficient diabetes | PD-1/PD-L1 | High glucose, ketones, very low C-peptide | Yes | Insulin; treat DKA |
| Primary adrenal insufficiency | PD-1/PD-L1 or combination | Low cortisol, high ACTH, high renin | Yes | Hydrocortisone and [fludrocortisone](https://durgical.com/en/pharmacology/fludrocortisone/) |
| Hypoparathyroidism | Any, very rare | Low calcium, low PTH | Usually yes | Calcium and active [vitamin D](https://durgical.com/en/biochemistry/molecules/vitamin-d/) |

## Keys to the differential

- Fatigue, nausea and low sodium on immunotherapy are easily blamed on the cancer; a morning cortisol and ACTH make the diagnosis of hypophysitis or adrenal failure.
- Headache in the first months of ipilimumab-containing therapy suggests hypophysitis; a pituitary MRI usually shows enlargement, whereas PD-1-related hypophysitis often does not.
- A low TSH can mean two opposite things on checkpoint inhibitors: thyroiditis if free T4 is high, central hypothyroidism if free T4 is low.
- Patients already taking glucocorticoids for another immune side effect have suppressed cortisol tests; their adrenal axis is assessed after the steroids are tapered.

## Next step / Initial management

- Check TSH, free T4 and glucose before every cycle, and morning cortisol with ACTH whenever there is fatigue, hypotension, hyponatraemia or headache.
- Start hydrocortisone at once for adrenal insufficiency, before levothyroxine; give stress-dose treatment and admit if there is hypotension or vomiting.
- Treat new hyperglycaemia with ketones as DKA and start insulin; measure C-peptide and diabetes antibodies to confirm insulin deficiency.
- Continue immunotherapy in most patients once hormone replacement is established, with the oncology team; replacement is usually lifelong.
- Refer to endocrinology every patient with hypophysitis, adrenal insufficiency, new diabetes or hypoparathyroidism, and thyroiditis that is severe or not following the usual course.

## Common traps

- **Checkpoint thyroiditis needs an antithyroid drug**: the thyrotoxic phase is destructive release of stored hormone, so antithyroid drugs do nothing and a beta-blocker is enough.
- **High-dose glucocorticoids will rescue the gland**: endocrine damage is usually permanent and steroids do not restore function, so replacement is the treatment.
- **A low TSH always means too much thyroid hormone**: with hypophysitis TSH is low or normal while free T4 is low, which is central hypothyroidism.
- **Levothyroxine can be started straight away for low free T4**: if ACTH is also deficient, thyroxine first can precipitate adrenal crisis, so cortisol is replaced first.
- **Endocrine side effects mean immunotherapy must stop**: once hormones are replaced most patients can continue, and stopping would sacrifice cancer control for a manageable deficit.

## Test yourself

Think of the answer, then tap the question to see it.

## Six weeks into pembrolizumab a man has palpitations, a suppressed TSH and a high free T4, with low radioiodine uptake. What is it and how is it treated?

Painless destructive thyroiditis: a beta-blocker for symptoms, no antithyroid drugs, and repeat tests in a few weeks because hypothyroidism usually follows.

## A woman on ipilimumab plus nivolumab has headache, fatigue and sodium of 128 mmol/L; TSH is low-normal and free T4 low. What do you check and give first?

Morning cortisol and ACTH for hypophysitis, and hydrocortisone first, before levothyroxine, because ACTH deficiency is the dangerous deficit.

## A patient on a PD-1 inhibitor presents with vomiting, glucose of 480 mg/dL, ketones and an HbA1c of only 7.2%. What is the diagnosis?

Checkpoint-inhibitor insulin-deficient diabetes presenting as DKA; the rapid onset explains the modest HbA1c, C-peptide is very low and insulin is needed for life.

## Once a patient with checkpoint-induced hypothyroidism is stable on levothyroxine, should immunotherapy be stopped?

Usually not: endocrine adverse events are managed with replacement, and immunotherapy continues with the oncology team.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/endocrinology/endocrine-side-effects-of-immune-checkpoint-inhibitors/)

## Elsewhere in DurgiPedia

- [Cancer immunotherapy: checkpoint inhibitors, CAR-T and vaccines](https://durgical.com/en/immunology/cancer-immunotherapy-checkpoint-inhibitors-car-t-and-vaccines/)
- [Antibodies, bispecifics and CAR-T cells: how they work and their emergencies (CRS, ICANS)](https://durgical.com/en/haematology/antibodies-bispecifics-and-car-t-cells-how-they-work-and-their-emergencies/)
- [Other thyroiditis: de Quervain, painless, Riedel](https://durgical.com/en/general-pathology/other-thyroiditis-de-quervain-painless-riedel/)
- [Adrenocortical insufficiency](https://durgical.com/en/general-pathology/adrenocortical-insufficiency/)

## Connections

## See it in 3D 4

The structures of Durgical's 3D anatomy where it is found.

- [Pituitary gland](https://durgical.com/en/anatomy/pituitary-gland/)
- [Thyroid gland](https://durgical.com/en/anatomy/thyroid-gland/)
- [Pancreas](https://durgical.com/en/anatomy/pancreas/)
- [Left adrenal gland](https://durgical.com/en/anatomy/left-suprarenal-gland/)

## Related 8

- [Thyrotoxicosis: finding the cause](https://durgical.com/en/endocrinology/thyrotoxicosis-finding-the-cause/)
- [Hypothyroidism: overt, subclinical and central](https://durgical.com/en/endocrinology/hypothyroidism-overt-subclinical-and-central/)
- [Adrenal insufficiency: primary or central?](https://durgical.com/en/endocrinology/adrenal-insufficiency-primary-or-central/)
- [Replacing pituitary hormones: what order and how to monitor](https://durgical.com/en/endocrinology/replacing-pituitary-hormones-what-order-and-how-to-monitor/)
- [Diabetic ketoacidosis and the hyperosmolar hyperglycaemic state](https://durgical.com/en/endocrinology/diabetic-ketoacidosis-and-the-hyperosmolar-hyperglycaemic-state/)
- [Low calcium: PTH, magnesium and vitamin D](https://durgical.com/en/endocrinology/low-calcium-pth-magnesium-and-vitamin-d/)
- [Autoimmune polyglandular syndromes](https://durgical.com/en/endocrinology/autoimmune-polyglandular-syndromes/)
- [Medicines that change endocrine tests and glands](https://durgical.com/en/endocrinology/medicines-that-change-endocrine-tests-and-glands/)

## Related conditions 9

- [Thyroiditis (subacute, painless and postpartum)](https://durgical.com/en/conditions/thyroiditis/)
- [Hypothyroidism](https://durgical.com/en/conditions/hypothyroidism/)
- [Hypopituitarism (incl. Sheehan syndrome and pituitary apoplexy)](https://durgical.com/en/conditions/hypopituitarism/)
- [Adrenal insufficiency](https://durgical.com/en/conditions/adrenal-insufficiency/)
- [Adrenal crisis](https://durgical.com/en/conditions/adrenal-crisis/)
- [Type 1 diabetes mellitus](https://durgical.com/en/conditions/type-1-diabetes-mellitus/)
- [Diabetic ketoacidosis](https://durgical.com/en/conditions/diabetic-ketoacidosis/)
- [Hypoparathyroidism (incl. post-thyroidectomy hypocalcaemia)](https://durgical.com/en/conditions/hypoparathyroidism/)
- [Melanoma](https://durgical.com/en/conditions/melanoma/)

## In Pharmacology 10

- [Immune checkpoint inhibitors](https://durgical.com/en/pharmacology/classes/immune-checkpoint-inhibitors/)
- [Ipilimumab](https://durgical.com/en/pharmacology/ipilimumab/)
- [Nivolumab](https://durgical.com/en/pharmacology/nivolumab/)
- [Pembrolizumab](https://durgical.com/en/pharmacology/pembrolizumab/)
- [Hydrocortisone](https://durgical.com/en/pharmacology/hydrocortisone/)
- [Fludrocortisone](https://durgical.com/en/pharmacology/fludrocortisone/)
- [Levothyroxine](https://durgical.com/en/pharmacology/levothyroxine/)
- [Insulins](https://durgical.com/en/pharmacology/classes/insulins/)
- [Beta blockers](https://durgical.com/en/pharmacology/classes/beta-blockers/)
- [Calcitriol](https://durgical.com/en/pharmacology/calcitriol/)

[← All of endocrinology](https://durgical.com/en/endocrinology/)

Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.

Sources: [Endocrine-Related Adverse Events From Immune Checkpoint Inhibitors](https://www.ncbi.nlm.nih.gov/books/NBK594266/) (StatPearls (NCBI Bookshelf), 2026); [Lymphocytic Hypophysitis](https://www.ncbi.nlm.nih.gov/books/NBK562255/) (StatPearls (NCBI Bookshelf), 2025); [Adrenal Insufficiency](https://www.ncbi.nlm.nih.gov/books/NBK441832/) (StatPearls (NCBI Bookshelf), 2023).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/endocrinology/endocrine-side-effects-of-immune-checkpoint-inhibitors/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/endocrinology/endocrine-side-effects-of-immune-checkpoint-inhibitors/
